Oral presentation at 22nd Annual WORLDSymposium highlights sustained knockdown of GYS1 mRNA, favorable safety and tolerability, predictable pharmacokinetics, and biomarker reductions consistent with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results